Mirum Pharmaceuticals (MIRM) EV to CFO (2024 - 2025)
Mirum Pharmaceuticals' (MIRM) EV to CFO was 66.56 for Q4 2025, down 60.0% from 166.40 a year earlier and down 12.2% from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) EV to CFO (2024 - 2025) Analysis & Trends
Dating back to Q4 2024, Mirum Pharmaceuticals' EV to CFO record includes 4 quarters.
- By year, EV to CFO came in at 166.40 in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Mirum Pharmaceuticals | 5.67 Bn | 4.09 Bn | 145.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 66.56 |
| Sep 30, 2025 | 75.77 |
| Jun 30, 2025 | 249.35 |
| Dec 31, 2024 | 166.40 |
API Access
Mirum Pharmaceuticals EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();